medigraphic.com
ISSN 1561-3070 (Digital)

2013, Número 1

<< Anterior Siguiente >>

Rev Cub Oftal 2013; 26 (1)


Manifestaciones neuroftalmológicas en la enfermedad de Parkinson

Rodríguez MYN, Pola AL, Juvier RT, Cabal RR, Soto LA, Pérez GE

Idioma: Español
Referencias bibliográficas: 60
Paginas: 170-179
Archivo PDF: 52.81 Kb.


RESUMEN

La enfermedad de Parkinson es un desorden neurodegenerativo progresivo provocado por un déficit de dopamina que desencadena importantes alteraciones motoras y no motoras. Dentro de estas, un considerable grupo constituye motivo de interés para el neuroftalmólogo. La enfermedad ha sido siempre más reconocida por sus alteraciones motoras. El objetivo fundamental de esta revisión es hacer énfasis en el diagnóstico de las afectaciones visuales en la enfermedad de Parkinson y de esta forma mejorar en lo posible la calidad de vida de los pacientes. Se realizó una amplia búsqueda en PUBMED y se revisaron 60 artículos relacionados con el tema, publicados entre los años 1984 y 2012.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Hristova D, Zachariev Z, Mateva N, Grozdev I. Incidence of Parkinson's disease in Bulgaria. Neuroepidemiology. 2010;34(2):76-82.

  2. Dotchin C, Msuya O, Kissima J, Massawe J, Mhina A, Moshy A, et al. The prevalence of Parkinson's disease in rural Tanzania. Mov Disord. 2008;23(11):1567-72.

  3. Allan HR, Martin AS. Adams & Victor's Principles of Neurology. 9na ed. Boston: The McGraw-Hill Companies; 2009.

  4. Daniel SE, Lees AJ. Parkinson's Disease Society Brain Bank. London: overview and research. J Neural Transm Suppl. 1993;39:165-72.

  5. Chaudhuri KR, Healy DG, Schapira AH; National Institute for Clinical Excellence. Non-motor symptoms of Parkinson's disease: diagnosis and management. Lancet Neurol. 2006;5(3):235-45.

  6. Armstrong RA. Visual symptoms in Parkinson's disease. Parkinsons Dis. 2011;908306.

  7. Bernal-Pacheco O, Limotai N, Go CL, Fernández HH. Non-motor manifestations in Parkinson disease. Neurologist. 2012;18(1):1-16.

  8. Jones RD, Donaldson IM, Timmings PL. Impairment of high-contrast visual acuity in Parkinson's disease. Mov Dis. 1992;7(3):232-8.

  9. Biousse V, Skibell BC, Watts RL, Loupe DN, Drews-Botsch C, Newman NJ. Ophthalmologic features of Parkinson's disease. Neurology. 2004;62(2):177-80.

  10. Tamer C, Melek IM, Duman T, Oksüz H. Tear film tests in Parkinson's disease patients. Ophthalmology. 2005;112(10):1795.

  11. Seichepine DR, Neargarder S, Miller IN, Riedel TM, Gilmore GC. A relation of Parkinson's disease subtypes to visual activities of daily living. J Int Neuropsychol Soc. 2011;17(5):841-52.

  12. Matsui H, Udaka F, Tamura A, Oda M, Kubori T, Nishinaka K, et al. Impaired visual acuity as a risk factor for visual hallucinations in Parkinson's disease. J Geriatric Psychiatry Neurology. 2006;19(1):36-40.

  13. Barnesa J, Davida AS. Visual hallucinations in Parkinson's disease: a review and phenomenological survey. J Neurol Neurosurg Psychiatry. 2001;70(6):727-33.

  14. Williams DR, Lee AJ. Visual hallucinations in the diagnosis of idiopathic Parkinson's disease: a retrospective autopsy study. The Lancet Neurology. 2005;4(10):605-10.

  15. Geldmacher DS. Visuospatial dysfunction in the neurodegenerative diseases. Front Biosci. 2003;8:e42836.

  16. Crucian GP, Okun MS. Visual-spatial ability in Parkinson's disease. Front Biosci. 2003;8:s992-7.

  17. Meppelink AM, de Jong BM, Renken R, Leenders KL, Cornelissen FW, van Laar T. Impaired visual processing preceding image recognition in Parkinson's disease patients with visual hallucinations. Brain. 2009;132(Pt 11):2980-93.

  18. Regan D, Neima D. Low-contrast letter charts in early diabetic retinopathy, ocular hypertension, glaucoma, and Parkinson's disease. Br J Ophthalmol. 1984;68(12):885-9.

  19. Pieri V, Diederich NJ, Raman R, Goetz CG. Decreased color discrimination and contrast sensitivity in Parkinson's disease. J Neurol Sci. 2000;172(1):7-11.

  20. Bulens C, Meerwaldt JD, Van Der Wildt GJ, Keemink CJ. Visual contrast sensitivity in drug-induced Parkinsonism. J Neurology Neurosurgery Psychiatry. 1989;52:341-5.

  21. Regan D, Maxner C. Orientation-selective visual loss in patients with Parkinson's disease. Brain. 1987;110(Pt 2):41532.

  22. Motoyoshi I. Attentional Modulation of Temporal Contrast Sensitivity in Human Vision. PLoS ONE. 2011;6(4):e19303.

  23. Menon GJ. Complex visual hallucinations in the visually impaired. A structured history-taking approach. Arch Ophthalmol. 2005;123(3):349-55.

  24. Jackson ML, Bassett K, Nirmalan PV, Sayre EC. Contrast sensitivity and visual hallucinations in patients referred to a low vision rehabilitation clinic. Br J Ophthalmol. 2007;91(3):296-8.

  25. Wall M, Johnson CA. Principles and Techniques of the Examination of the Visual Sensory System. En: Miller NR, Newman NJ, Biousse V, Kerrison JB. editors. Walsh and Hoyt's Clinical Neuro-ophthalmology. Baltimore: Lippincott Williams & Wilkins; 2005. p. 293-349.

  26. Price MJ, Feldman RG, Adelberg D, Kayne H. Abnormalities in color vision and contrast sensitivity in Parkinson's disease. Neurology. 1992;42(4):887-90.

  27. Muller T, Kuhn W, Buttner T, Eising E, Coenen H, Haas M, et al. Colour vision abnormalities do not correlate with dopaminergic nigrostriatal degeneration in Parkinsons disease. J Neurol. 1998;245(10):659-64.

  28. Muller T, Meisel M, Russ H, Przuntek H. Motor impairment influences Farnsworth- Munsell 100 Hue test error scores in Parkinsons disease patients. J Neurol Sci. 2003;213(1-2):61-5.

  29. Diederich NJ, Raman R, Leurgans S, Goetz CG. Progressive worsening of spatial and chromatic processing deficits in Parkinson disease. Arch Neurol. 2002;59(8):1249-52.

  30. Buttner T, Kuhn W, Klotz P, Steinberg R, Voss L, Bulgaru D, et al. Disturbance of colour perception in Parkinson's disease. J Neural Transm Park Dis Dement Sect. 1993;6(1):11-5.

  31. Buttner T, Kuhn W, Muller T, Patzold T, Heidbrink K, Przuntek H. Distorted color discrimination in de novo parkinsonian patients. Neurology. 1995;45(2):386-7.

  32. Muller T, Kuhn W, Buttner T, Przuntek H. Colour vision abnormalities and movement time in Parkinsons disease. Eur J Neurol. 1999;6(6):711-5.

  33. Postuma RB, Gagnon JF, Vendette M, Charland K, Montplaisir J. Manifestations of Parkinson disease differ in association with REM sleep behavior disorder. Mov Disord. 2008;23(12):1665-72.

  34. Oh YS, Kim JS, Chung SW, Song IU, Kim YD, Kim YI, et al. Color vision in Parkinson's disease and essential tremor. Eur J Neurol. 2011;18(4):577-83.

  35. Lee AC, Harris JP, Atkinson EA, Nithi K, Fowler MS. Dopamine and the representation of the upper visual field: evidence from vertical bisection errors in unilateral Parkinson's disease. Neuropsychologia. 2002;40(12):2023-9.

  36. Yenice O, Onal S, Midi I, Ozcan E, Temel A, I-Gunal D. Visual field analysis in patients with Parkinson's disease. Parkinsonism Relat Disord. 2008;14(3):193-8.

  37. Ture S, Inci I, Gedizlioglu M. Abnormalities of contrast sensitivity, visual fields and visual evoked potentials in Parkinson's disease and effect of dopaminergic treatment. J Neurology. 2007;254(suppl 3):p. 93.

  38. Bayer AU, Keller ON, Ferrari F, Maag KP. Association of glaucoma with neurodegenerative diseases with apoptotic cell death: Alzheimer's disease and Parkinson's disease. Amer J Ophthalmol. 2002;133(1):135-7.

  39. Burguera JA, Vilela C, Traba A, Ameave Y, Vallet M. The electroretinogram and visual evoked potentials in patients with Parkinson's disease. Arch Neurobiol. 1990;53(1):1-7.

  40. Sener HO, Akbostanci MC, Yaesan C, Dora B, Seauki D. Visual evoked potentials in Parkinson's disease-correlation with clinical involvement. Clin Neurol Neurosurg. 2001;103(3):147-50.

  41. Goab M, Fabian A, Honczarenko K. Significance of visual evoked potentials (VEP) in the diagnosis of Parkinson disease. Neurol Neurochir Pol. 2003;37 Suppl 5:145-54.

  42. Tagliati M, Bodis-Wollner I, Yahr MD. The pattern electroretinogram in Parkinson's disease reveals lack of retinal spatial tuning. Electroencephalogr Clin Neurophysiol. 1996;100(1):1-11.

  43. Büttner T, Kuhn W, Müller T, Heinze T, Pühl C, Przuntek H. Chromatic and achromatic visual evoked potentials in Parkinson's disease. Electroencephalogr Clin Neurophysiol. 1996;100(5):443-7.

  44. Langheinrich T, Tebartz L, Lagrèze WA, Bach M, Lücking CH, Greenlee MW. Visual contrast response functions in Parkinson's disease: evidence from electroretinograms, visually evoked potentials and psychophysics. Clin Neurophysiol. 2000;111(1):66-74.

  45. Sartucci F, Orlandi G, Lucetti C, Bonuccelli U, Murri L, Orsini C, et al. Changes in pattern electroretinograms to equiluminant red-green and blue-yellow gratings in patients with early Parkinson's disease. J Clin Neurophysiol. 2003;20(5):375-81.

  46. Sartucci F, Orlandi G, Bonuccelli U, Borghetti D, Murri L, Orsini C, et al. Chromatic pattern-reversal electroretinograms (ChPERGs) are spared in multiple system atrophy compared with Parkinson's disease. Neurol Sci. 2006;26(6):395-401.

  47. Sannita WG, Carozzo S, Orsini P, Domenici L, Porciatti V, Fioretto M, et al. Gamma band oscillatory response to chromatic stimuli in volunteers and patients with idiopathic Parkinson's disease. Vision Res. 2009;49(7):726-34.

  48. Nowacka B, Lubiñski W, Karczewicz D. Ophthalmological and electrophysiological features of Parkinson's disease. Klin Oczna. 2010;112(7-9):247-52.

  49. Moschos MM, Tagaris G, Markopoulos I, Margetis I, Tsapakis S, Kanakis M, et al. Morphologic changes and functional retinal impairment in patients with Parkinson disease without visual loss. Eur J Ophthalmol. 2011;21(1):24-9.

  50. Jindahra P, Hedges TR, Mendoza-Santiesteban CE, Plant GT. Optical coherence tomography of the retina: applications in neurology. Curr Opin Neurol. 2010;23(1):16-23.

  51. Huang YM, Yin ZQ. Minor retinal degeneration in Parkinson's disease. Med Hypotheses. 2011;76(2):194-6.

  52. Inzelberg R, Ramirez JA, Nisipeanu P, Ophir A. Retinal nerve fiber layer thinning in Parkinson disease. Vision Res. 2004;44(24):27937.

  53. Altintas O, Iseri PK, Ozkan B, Caglar Y. Correlation between retinal morphological and functional findings and clinical severity in Parkinson's disease. Doc Ophthalmol. 2008;116(2):137-46.

  54. Hajee ME, March WF, Lazzaro DR, Wolintz AH, Shrier EM, Glazman S, Bodis- Wollner IG. Inner retinal layer thinning in Parkinson disease. Arch Ophthalmol. 2009;127(6):737-41.

  55. Cubo E, Tedejo RP, Rodriguez V, López MJ, Trejo Gabriel JM. Retina thickness in Parkinson's disease and essential tremor. Mov Disord. 2010;25(14):2461-2.

  56. Archibald NK, Clarke MP, Mosimann UP, Burn D.J. Retinal thickness in Parkinson's disease. Parkinsonism Relat Disord. 2011;17(6):431-6.

  57. Tasman W, Jaeger E editores. Duane´s Ophthalmology [CD-ROM]. Philadelphia: Lippincott Williams & Wilkins; 2006.

  58. Almer Z, Klein KS, Marsh L, Gerstenhaber M, Repka MX. Ocularmotor and sensory function in Parkinson's disease. Ophthalmology. 2012;119(1):178-82.

  59. Van Koningsbruggen MG, Pender T, Machado L, Rafal RD. Impaired control of the oculomotor reflexes in Parkinson's disease. Neuropsychologia. 2009;47(13):290915.

  60. Pinkhardt EH, Kassubek J. Ocular motor abnormalities in Parkinsonian syndromes. Parkinsonism Relat Disord. 2011;17(4):223-30.




2020     |     www.medigraphic.com